Chemotherapy-induced peripheral neuropathy (CIPN) can be considered a phantom pain because the sensations of CIPN have no concurrent input into the nervous system. In fact, the damage that is done to the peripheral nerves is, as we know to date, irreversible. There are limited data supporting the use of neuromodulatory techniques to treat CIPN and no trials with aims for prevention. The objective of this article is to review current research on neurofeedback to treat CIPN.

You do not currently have access to this content.